VG Life Sciences VGLS Stock
VG Life Sciences Price Chart
VG Life Sciences VGLS Financial and Trading Overview
VG Life Sciences stock price | 0.0000 USD |
Previous Close | 5.0E-5 USD |
Open | 0.0001 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.0001 - 0.0001 USD |
52 Week Range | 1.0E-5 - 0.0003 USD |
Volume | 185.05K USD |
Avg. Volume | 1.93M USD |
Market Cap | 3.65M USD |
Beta (5Y Monthly) | 2.809154 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VGLS Valuation Measures
Enterprise Value | 4.01M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
VG Life Sciences Stock Price History
Beta (5Y Monthly) | 2.809154 |
52-Week Change | 0% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.0003 USD |
52 Week Low | 1.0E-5 USD |
50-Day Moving Average | 7.16E-5 USD |
200-Day Moving Average | 8.395E-5 USD |
VGLS Share Statistics
Avg. Volume (3 month) | 1.93M USD |
Avg. Daily Volume (10-Days) | 1.49M USD |
Shares Outstanding | 107.88M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0.029% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:600 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2014 |
Most Recent Quarter (mrq) | September 30, 2015 |
Next Fiscal Year End | December 31, 2015 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -151.17% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | -4298716 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 22.92K USD |
Total Cash Per Share (mrq) | 0 USD |
Total Debt (mrq) | 3.38M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.007 |
Book Value Per Share (mrq) | -0.049 |
Cash Flow Statement
Operating Cash Flow (ttm) | -858336 USD |
Levered Free Cash Flow (ttm) | -1462855 USD |
Profile of VG Life Sciences
Country | United States |
State | CA |
City | Santa Barbara |
Address | 121 Gray Avenue |
ZIP | 93101 |
Phone | 805 879 9000 |
Website | https://www.vglifesciences.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 1 |
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is displayed on specific B cells that leads to chronic inflammation. The company also provides metabolic disruption technology (MDT) compounds impede tumor cells that sensitize cancer cells to treatment by disrupting the metabolic strategies those cells use to survive; and Hydroxychloroquine, a MDT compound that can be used in combination with other cancer drugs for treating drug-resistant cancers. In addition, it offers targeted peptide technology (TPT), a technology that eliminates the subpopulation of pro-inflammatory immune cells and presents a possible treatment for autoimmune and infectious diseases. VG Life Sciences Inc. was formerly known as Viral Genetics Inc. and changed its name to VG Life Sciences Inc. in November 2012. The company was founded in 1995 and is based in Santa Barbara, California. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd.
Q&A For VG Life Sciences Stock
What is a current VGLS stock price?
VG Life Sciences VGLS stock price today per share is 0.0000 USD.
How to purchase VG Life Sciences stock?
You can buy VGLS shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for VG Life Sciences?
The stock symbol or ticker of VG Life Sciences is VGLS.
Which industry does the VG Life Sciences company belong to?
The VG Life Sciences industry is Biotechnology.
How many shares does VG Life Sciences have in circulation?
The max supply of VG Life Sciences shares is 0.
What is VG Life Sciences Price to Earnings Ratio (PE Ratio)?
VG Life Sciences PE Ratio is now.
What was VG Life Sciences earnings per share over the trailing 12 months (TTM)?
VG Life Sciences EPS is 0 USD over the trailing 12 months.
Which sector does the VG Life Sciences company belong to?
The VG Life Sciences sector is Healthcare.